The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
Study Suggests Aspirin, Other Anticoagulants Have Protective Effect Against Diabetic Retinopathy
Antiplatelet/anticoagulant (APAC) therapy can protect patients from developing nonproliferative diabetic retinopathy, according to a recent study.
How Will the Glaucoma Treatment Landscape Evolve in Coming Years?
Shared insight on how the use and sequencing of therapies for glaucoma will evolve in coming years.
Dr Shoaib Ugradar Discusses Teprotumumab for Thyroid Eye Disease and Data Collected
Teprotumumab has shown great efficacy in treating thyroid eye disease in both clinical trials and real-world settings, but more data are needed on adverse events, said Shoaib Ugradar, MD, UCLA Stein Eye Center Santa Monica.
Glaucoma: Considering MIGS and Other Channel Procedures
Expert panelists review the use of MIGS and other channel procedures in patients with glaucoma.
Level of VEGF in Tears Could Predict Age-Related Macular Degeneration, According to Study
Assessing the presence of vascular endothelial growth factor (VEGF) in tears could be a noninvasive way to determine the severity and progression of age-related macular degeneration.
Selective Laser Trabeculoplasty Use in Glaucoma
A review of selective laser trabeculoplasty in glaucoma management, and when it is appropriate to consider as a treatment option.
Darren Chen: Overall, Patients Were Satisfied With Ophthalmic Video Visits
A majority of patients with ophthalmic video visits were satisfied, but there were some predictors that contributed to which patients were more satisfied, explained Darren Chen, MD student at Weill Cornell Graduate School of Medical Sciences.
Novel Therapy in Glaucoma: Sustained Delivery Implants
A review of the novel sustained release approach with bimatoprost implants and how this is affecting glaucoma management.
Teleretinal Screening Appears Effective at Diagnosing Diabetic Retinopathy
The meta-analysis found insufficient evidence to assess the validity of the screening in diagnosing age-related macular degeneration.
Dr Robert Fante: More Data Will Provide More Insight Into Use of Teprotumumab for TED
As more data are gathered on teprotumumab for use in thyroid eye disease (TED), we’ll have a better understanding of which subgroups respond better or worse to the treatment, explained Robert G. Fante, MD, FACS, president of the American Society of Ophthalmic Plastic & Reconstructive Surgery and facial plastic surgeon and cosmetic surgeon, Fante Eye & Face Centre in Denver, Colorado.
Dr Steven Yeh Discusses Xipere Delivery Mechanism and Benefits
Steven Yeh, MD, professor of ophthalmology at the Truhlsen Eye Institute at the University of Nebraska Medical Center, explains the delivery mechanism and benefits of Xipere for macular edema.
Use of Rho Kinase Inhibitors in Glaucoma
Panelists discuss the role of rho kinase inhibitors in glaucoma management respective to cost, efficacy, and ease of use.
Addressing Patient Adherence in Glaucoma Management
Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens.
Early Retinal Vascular Density Deficiency May Indicate Risk of Visual Field Loss in Glaucoma
A small study found that decreased retinal vascular density identified by optical coherence tomography angiography may be linked to faster visual field loss at extended follow-up.
Researchers: Future Investigations on Screen Time, Eye Health Are Warranted
Judith Lavrich, MD, and Jordan Hamburger discuss the need for more research on the impact of screen time on eye health following their study on virtual school and children's eyesight.
Factors Guiding Selection of Therapy for Glaucoma
Expert perspectives on the factors that inform therapy selection when managing patients with glaucoma.
Considering Generic Vs Branded Therapy for Glaucoma
Experts debate the use of generic agents over branded therapy when managing patients with glaucoma.
Case-Control Study Identifies Potential Link Between COVID-19, Chronic Dacryoadenitis
SARS-CoV-2 might target lacrimal glands, causing eyelid swelling due to chronic dacryoadenitis after COVID-19 infection.
Dr David Ramsey Explains the Importance of Eye Examinations in Patients With Diabetes
David Ramsey, MD, PhD, MPH, outlines why patients with diabetes should undergo regular eye examinations.
An Overview of Treatment Options for Glaucoma
A broad review of therapeutic classes approved for the management of glaucoma and how they may be sequenced.
Glaucoma: Utilization Management and Patient Access to Therapy
Following a brief discussion on utilization management, experts discuss the current paradigm of patient access to therapy.
Dr James Auran Outlines How to Address Shortages of Ophthalmic Trauma Care Providers
James Auran, MD, a professor of ophthalmology at Columbia University Irving Medical Center and president of the American Society of Ophthalmic Trauma, lists potential solutions to bolster ophthalmic trauma care in the United States.
Xipere for Macular Edema Associated With Uveitis Launches in United States
The treatment was approved in October 2021 and is the first FDA-approved therapy to treat macular edema associated with uveitis via injection to the suprachoroidal space, which provides a more targeted delivery mechanism.
Goals of Therapy When Treating Glaucoma
Experts highlight early detection and the goals of therapy when managing patients with glaucoma.
The Importance of Vision Preservation in Patients With Glaucoma
A brief overview of vision preservation in glaucoma and the importance of preventing peripheral vision loss and patient falls.
Plasma THC Levels Associated With Reduced Intraocular Pressure in Healthy Adults
A recent analysis found a strong negative correlation between plasma THC levels and intraocular pressure in healthy adults after smoking cannabis.
Dr Anne Barmettler Discusses Potential Adverse Events Associated With Teprotumumab
Anne Barmettler, MD, an associate professor of ophthalmology, visual sciences, and plastic surgery at Montefiore Medical Center, outlines adverse events patients taking teprotumumab for thyroid eye disease may experience.
Dr Leon Herndon on Tailoring Glaucoma Care for Older Patients
Leon Herndon Jr, MD, a glaucoma specialist, ophthalmologist, and professor of ophthalmology at the Duke University Eye Center, explains how older patients with glaucoma may lose nerve fiber layer at a quicker rate than younger patients.
FDA Approves Faricimab to Treat Wet AMD and DME
This represents the approval of the first bispecific antibody to treat wet age-related macular degeneration (AMD) and diabetic macular edema (DME).
Could AI–Based Real-Time Surgical Guidance Reduce Complications During Cataract Surgery?
A recent study suggests a conceptual deep neural network–based surgical guidance platform is precise and has potential as a valuable tool during phacoemulsification procedures.
2 Clarke Drive Cranbury, NJ 08512